Alto Neuroscience (ANRO) Institutional Ownership $4.46 +0.23 (+5.44%) As of 01/30/2025 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Alto Neuroscience (NYSE:ANRO)Number ofInstitutional Buyers(last 12 months)28TotalInstitutional Inflows(last 12 months)$80.43MNumber ofInstitutional Sellers(last 12 months)5TotalInstitutional Outflows(last 12 months)$5.05M Get ANRO Insider Trade Alerts Want to know when executives and insiders are buying or selling Alto Neuroscience stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data ANRO Institutional Buying and Selling by Quarter Alto Neuroscience Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails1/30/2025Rhumbline Advisers25,556$108K0.0%+24.4%0.095% 12/26/2024JPMorgan Chase & Co.24,315$278K0.0%+543.4%0.090% 11/27/2024Franklin Resources Inc.1,220,712$13.97M0.0%+95.3%4.526% 11/19/2024Barclays PLC29,599$339K0.0%+872.7%0.110% 11/16/2024Geode Capital Management LLC469,988$5.38M0.0%+148.7%1.743% 11/15/2024Barclays PLC29,599$339K0.0%+872.7%0.110% 11/15/2024Jane Street Group LLC10,817$124K0.0%N/A0.040% 11/15/2024Wellington Management Group LLP60,636$694K0.0%N/A0.225% 11/15/2024State Street Corp236,857$2.71M0.0%+123.7%0.878% 11/15/2024RA Capital Management L.P.2,075,154$23.74M0.3%-0.5%7.694% Get the Latest News and Ratings for ANRO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Alto Neuroscience and its competitors with MarketBeat's FREE daily newsletter. 11/15/2024Philadelphia Financial Management of San Francisco LLC449,952$5.15M0.8%+1.5%1.668% 11/15/2024Point72 Asset Management L.P.977,692$11.19M0.0%-6.9%3.625% 11/14/2024Fred Alger Management LLC181,435$2.08M0.0%+56.1%0.673% 11/14/2024Vestal Point Capital LP650,000$7.44M0.6%+4.8%2.411% 11/14/2024MetLife Investment Management LLC12,783$146K0.0%N/A0.047% 11/13/2024BNP Paribas Financial Markets4,315$49K0.0%+619.2%0.016% 11/13/2024FMR LLC2,363,056$27.03M0.0%+1.4%8.765% 11/13/2024The Manufacturers Life Insurance Company65,805$753K0.0%+84.5%0.244% 11/13/2024Bowie Capital Management LLC19,484$223K0.0%-54.9%0.072% 11/12/2024Charles Schwab Investment Management Inc.186,968$2.14M0.0%+182.5%0.694% 11/12/2024Board of Trustees of The Leland Stanford Junior University79,740$912K0.1%-76.8%0.296% 11/8/2024 Jennison Associates LLC832,290$9.52M0.0%+80.3%3.087% 8/19/2024Point72 Asset Management L.P.1,050,037$11.23M0.0%-6.7%3.906% 8/14/2024Fred Alger Management LLC116,254$1.24M0.0%-1.5%0.432% 8/8/2024Federated Hermes Inc.12,000$128K0.0%+33.3%0.045% 8/6/2024Bowie Capital Management LLC43,186$462K0.0%N/A0.161% 8/3/2024TD Asset Management Inc86,792$928K0.0%N/A0.323% 8/1/2024Rhumbline Advisers10,539$113K0.0%N/A0.039% 7/26/2024Bank of New York Mellon Corp23,557$252K0.0%N/A0.088% 5/17/2024RA Capital Management L.P.1,385,491$21.27M0.3%N/A5.154% 5/17/2024Artal Group S.A.350,000$5.37M0.1%N/A1.302% 5/17/2024Zimmer Partners LP75,000$1.15M0.0%N/A0.279% 5/16/2024AWM Investment Company Inc.299,147$4.59M0.6%N/A1.113% 5/15/2024Price T Rowe Associates Inc. MD637,604$9.79M0.0%N/A2.372% 5/10/2024Vanguard Group Inc.536,332$8.23M0.0%N/A1.995% 5/2/2024 Jennison Associates LLC458,599$7.04M0.0%N/A1.706% 4/30/2024University of Texas Texas AM Investment Managment Co.22,175$340K0.1%N/A0.082% (Data available from 1/1/2016 forward) ANRO Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of ANRO shares? During the previous two years, 30 institutional investors and hedge funds held shares of Alto Neuroscience. The most heavily invested institutionals were FMR LLC ($27.03M), RA Capital Management L.P. ($23.74M), Franklin Resources Inc. ($13.97M), Point72 Asset Management L.P. ($11.19M), Price T Rowe Associates Inc. MD ($9.79M), Jennison Associates LLC ($9.52M), and Vanguard Group Inc. ($8.23M).Learn more on ANRO's institutional investors. Which institutional investors have been buying Alto Neuroscience stock? Of the 28 institutional investors that purchased Alto Neuroscience stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: RA Capital Management L.P. ($1.39M), Jennison Associates LLC ($829.21K), Price T Rowe Associates Inc. MD ($637.60K), Franklin Resources Inc. ($595.67K), Vanguard Group Inc. ($536.33K), Artal Group S.A. ($350K), and AWM Investment Company Inc. ($299.15K). How much institutional buying is happening at Alto Neuroscience? Institutional investors have bought a total of 5,761,115 shares in the last 24 months. This purchase volume represents approximately $80.43M in transactions. Which Alto Neuroscience major shareholders have been selling company stock? The following institutional investors have sold Alto Neuroscience stock in the last 24 months: Board of Trustees of The Leland Stanford Junior University ($264.27K), Point72 Asset Management L.P. ($147.31K), Bowie Capital Management LLC ($23.70K), RA Capital Management L.P. ($10.40K), and Fred Alger Management LLC ($1.76K). How much institutional selling is happening at Alto Neuroscience? Institutional investors have sold a total of 447,445 shares in the last 24 months. This volume of shares sold represents approximately $5.05M in transactions. Related Companies Keros Therapeutics Institutional Ownership GH Research Institutional Ownership Sage Therapeutics Institutional Ownership Mereo BioPharma Group Institutional Ownership SIGA Technologies Institutional Ownership Phathom Pharmaceuticals Institutional Ownership PureTech Health Institutional Ownership Arcturus Therapeutics Institutional Ownership ChromaDex Institutional Ownership Tourmaline Bio Institutional Ownership This page (NYSE:ANRO) was last updated on 1/31/2025 by MarketBeat.com Staff From Our Partners Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored#1 Crypto of 2025Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMan Who Called Nvidia Says: “Your Retirement Is Inside This Building.”In 2016, Jeff Brown called Nvidia at a split-adjusted 66 cents. The company just became the world's third $...Brownstone Research | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alto Neuroscience, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Alto Neuroscience With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
